Current and Past Smoking Significantly Increase Risk for Barrett's Esophagus

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 8, 2009, Pages 840-848

  Smith, Kylie J ^a   O'Brien, Suzanne M ^a   Green, Adèle C ^a   Webb, Penelope M ^a   Whiteman, David C ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BODY MASS; CONTROLLED STUDY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DYSPLASIA; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN TISSUE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PASSIVE SMOKING; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION; SMOKING HABIT; TELEPHONE;

ADULT; AGED; BARRETT ESOPHAGUS; BODY MASS INDEX; FEMALE; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; QUESTIONNAIRES; RISK FACTORS; SMOKING;

EID: 67949100668     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.04.018     Document Type: Article

References (41)

1. Sampliner R.E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus: the Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 93 (1998) 1028-1032
2. Shaheen N.J., Crosby M.A., Bozymski E.M., et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology 119 (2000) 333-338
3. Yousef F., Cardwell C., Cantwell M.M., et al. The incidence of esophageal cancer and highgrade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol 168 (2008) 237-249
4. Pera M., Cameron A.J., Trastek V.F., et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104 (1993) 510-513
5. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
6. Bollschweiler E., Wolfgarten E., Gutschow C., et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92 (2001) 549-555
7. Vizcaino A.P., Moreno V., Lambert R., et al. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 99 (2002) 860-868
8. Falk G.W. Barrett's esophagus. Gastroenterology 122 (2002) 1569-1591
9. Smith K.J., O'Brien S.M., Smithers B.M., et al. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 14 Pt 1 (2005) 2481-2486
10. Edelstein Z.R., Farrow D.C., Bronner M.P., et al. Central adiposity and risk of Barrett's esophagus. Gastroenterology 133 (2007) 403-411
11. Anderson L.A., Watson R.G., Murphy S.J., et al. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol 13 (2007) 1585-1594
12. Kubo A., Levin T.R., Block G., et al. Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control 20 (2009) 303-311
13. Corley D.A., Kubo A., Levin T.R., et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 133 (2007) 34-41 quiz 311
14. Cook M.B., Greenwood D.C., Hardie L.J., et al. A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. Am J Gastroenterol 103 (2008) 292-300
15. Shaheen N., and Ransohoff D.F. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. JAMA 287 (2002) 1972-1981
16. Sampliner R.E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 97 (2002) 1888-1895
17. Lagergren J., Bergstrom R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
18. Chow W.H., Finkle W.D., McLaughlin J.K., et al. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 274 (1995) 474-477
19. Rothman K.J., and Greenland S. Modern epidemiology. 2nd ed. (1998), Lippincott-Raven, Philadelphia 738
20. Andersson T., Alfredsson L., Källberg H., et al. Calculating measures of biological interaction. Eur J Epidemiol 20 (2005) 575-579
21. Veugelers P.J., Porter G.A., Guernsey D.L., et al. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus 19 (2006) 321-328
22. Kubo A., Levin T.R., Block G., et al. Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control 20 (2009) 303-311
23. Wu A.H., Wan P., and Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 12 (2001) 721-732
24. Gammon M.D., Schoenberg J.B., Ahsan H., et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89 (1997) 1277-1284
25. Pandeya N., Williams G.M., Sadhegi S., et al. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus. Am J Epidemiol 168 (2008) 105-114
26. Lindblad M., Rodriguez L.A., and Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 16 (2005) 285-294
27. IARC. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans (2002), World Health Organization International Agency for Research on Cancer, Lyon, France
28. Kendall B.J., Macdonald G.A., Hayward N.K., et al. Leptin and the risk of Barrett's oesophagus. Gut 57 (2008) 448-454
29. Wang K.K., and Sampliner R.E. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 103 (2008) 788-797
30. Sharma P. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction. Aliment Pharmacol Ther 20 Suppl 5 (2004) 48-54 discussion 61-62
31. Watson D.I., and Lally C.J. Prevalence of symptoms and use of medication for gastroesophageal reflux in an Australian community. World J Surg 33 (2009) 88-94
32. Statistics, A.B.o. National Health Survey: summary of results, Australia 2001. http://www.abs.gov.au/ausstats/abs.nsf/DetailsPage/4364.02001 Accessed September 8, 2008
33. DiSipio T., Rogers C., Newman B., et al. The Queensland Cancer Risk Study: behavioural risk factor results. Aust N Z J Public Health 30 (2006) 375-382
34. Murray L., Johnston B., Lane A., et al. Relationship between body mass and gastrooesophageal reflux symptoms: the Bristol Helicobacter Project. Int J Epidemiol 32 (2003) 645-650
35. Nilsson M., Johnsen R., Ye W., et al. Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol 39 (2004) 1040-1045
36. Cameron A.J., Zinsmeister A.R., Ballard D.J., et al. Prevalence of columnar-lined (Barrett's) esophagus: comparison of population-based clinical and autopsy findings. Gastroenterology 99 (1990) 918-922
37. Mezei G., and Kheifets L. Selection bias and its implications for case-control studies: a case study of magnetic field exposure and childhood leukaemia. Int J Epidemiol 35 (2006) 397-406
38. Rex D.K., Cummings O.W., Shaw M., et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125 (2003) 1670-1677
39. Hernan M.A., Hernandez-Diaz S., and Robins J.M. A structural approach to selection bias. Epidemiology 15 (2004) 615-625
40. Murphy S.J., Anderson L.A., Mainie I., et al. Incidence of colorectal cancer in a populationbased cohort of patients with Barrett's oesophagus. Scand J Gastroenterol 40 (2005) 1449-1453
41. Kapadia C.R. Short-segment Barrett's esophagus: prevalence, diagnosis, and associations. Gastroenterology 114 (1998) 409-411